Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1072-1076

  Manez, Rafael ^a   Kusne, Shimon ^a,b   Rinaldo, Charles ^a   Aguado, Jose Maria ^a   George, Kirsten St ^a   Grossi, Paolo ^a   Rye, Bonnie F ^a   Fung, John J ^a   Ehrlich, Garth D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; LEUKOCYTE; LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DETECTION;

EID: 0029894762     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1072     Document Type: Article

References (17)

1. Balfour HH Jr, Chace DA, Slaplelon JT, Simmons RL, Frid DS. A randomized, placebo controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 1989;320:1381-7.
2. Snydman DR, Werner BG, Heinze-Lacey B, et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 1987;317:1049-54.
3. Martin M, Manez R, Linden P, et al. A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1994;58:779-85.
4. Snydman DR, Werner BG, Dougherty N, et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. The Boston Center for Liver Transplantation CMVIG Study Group. Ann Intern Med 1993;119:984-91.
5. Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med 1994;120:375-81.
6. Fung J, Abu-Elmagd K, Jain A, et al. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc 1991;23:2977-83.
7. Manez R, St. George K, Linden P, et al. Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis. J Clin Microbiol 1994;32:2655-9.
8. Ljungman P, Griffiths P. Definitions of cytomegalovirus infections and disease. In: Michelson S, Plotkin SA, eds. Multidisciplinary approach to understanding of cytcmegalovirus disease. Paris: Elsevier Science Publishers, 1993:233-7.
9. Sirko DA, Ehrlich GD. PCR laboratory facilities, protocols and operations. In: Ehrlich GD, Greenberg SJ, eds. PCR-based diagnostics and infectious disease. Boston: Blackwell Scientific Publications, 1994:19-44.
10. Randhawa PS, Jaffe R, Faruki H, et al. Detection of cytomegalovirus in formalin-fixed paraffin-embedded donor, native and allograft liver tissue using a multiplex polymerase chain reaction-liquid hybridization assay. Mod Pathol 1994;7:125-8.
11. Gema G, Revello MG, Percivalle E, Zavanotti M, Parea M, Battaglia M. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 1990;28:2681-88.
12. Delgado R, Lumbrearas C, Alba C, et al. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol 1992;30:1876-8.
13. Gerna G, Zipeto D, Parea M, et al. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J Infect Dis 1991;164:488-98.
14. Randhawa PS, Manez R, Frye B, Ehrlich GD. Circulating immediate-early mRNA in patients with cytomegalovirus infections after solid organ transplantation. J Infect Dis 1994;170:1264-7.
15. Manez R, Kusne S, Green M, et al. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995;59:1010-4.
16. Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993;119:924-35.
17. van den Berg AP, van Son WJ, Haagsma EB, et al. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ . transplant recipients. Transplantation 1993;55:847-51.